SUPREFACT DEPOT 2 MONTHS
Google image searchProduct monograph
Active ingredient
buserelin (buserelin acetate), 6.3 MG
DIN: 02228955
Dosage form(s): IMPLANT
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription
Company: CHEPLAPHARM ARZNEIMITTEL GMBH
Date: 05-JUN-2020
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02A — HORMONES AND RELATED AGENTS (ATC, ATC/DDD)
- L02AE — Gonadotropin releasing hormone analogues (ATC, ATC/DDD)
- L02AE01 — BUSERELIN (ATC/DDD)
Reference brand drug: Suprefact
